National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Apr 18, 2018)
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018
This bill authorizes the Food and Drug Administration to partner with institutions of higher education to designate them as National Centers of Excellence in Continuous Pharmaceutical Manufacturing for the purpose of studying and recommending improvements to the process of continuous manufacturing of medications. (Currently, most medications are manufactured in batches.)
What just happenedApr 18, 2018
Referred to the House Committee on Energy and Commerce.
Who’s behind it
- Introduced in HouseApr 18, 2018
- Apr 18, 2018IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Apr 18, 2018IntroReferralIntro-H
Introduced in House
- Apr 18, 2018IntroReferral1000
Introduced in House